Click HERE to register

WEBINAR CONTENT DESCRIPTION:

This session will address how the U.S. Supreme Court’s recent Monsanto v. Durnell ruling impacts your case inventory beyond Roundup. With federal preemption a favorite defense of multinational pharmaceutical drug and medical device manufacturers, Durnell is sure to inspire new efforts to preempt out strong cases. While Wyeth will still run the show for FDA preemption cases, we explain what we expect to see from the defense bar, how you can anticipate those moves, and why Durnell’s impact should be limited to the world of pesticides.